Neurotransmitter-like intelligent transport vehicle: A new non-invasive nanomedicine

Treating spinal cord injury usually involves promoting axonal regeneration, but glial scars and other factors are insurmountable gaps. Activation of dormant relay pathways in the injected spinal cord is a new perspective on treatment. Although encouraging, due to the complexity of cell types in the remaining spinal cord, most drug carriers are only effective for a few spinal cord injuries. The nanocarrier disguised as a neurotransmitter has the effect of microenvironment ROS initiating targeted inhibition of a specific type of neuron, considering the binding of its neurotransmitter with neural inhibitors and encapsulating boron-based compounds. Treating spinal cord injury usually involves promoting axonal regeneration, but glial scars and other factors are insurmountable gaps. Activation of dormant relay pathways in the injected spinal cord is a new perspective on treatment. Although encouraging, due to the complexity of cell types in the remaining spinal cord, most drug carriers are only effective for a few spinal cord injuries. The nanocarrier disguised as a neurotransmitter has the effect of microenvironment ROS initiating targeted inhibition of a specific type of neuron, considering the binding of its neurotransmitter with neural inhibitors and encapsulating boron-based compounds.